NxStage Medical Revenue and Competitors

Location

$5.6M

Total Funding

Estimated Revenue & Valuation

  • NxStage Medical's estimated annual revenue is currently $300M per year.(i)
  • NxStage Medical's estimated revenue per employee is $436,681
  • NxStage Medical's total funding is $5.6M.

Employee Data

  • NxStage Medical has 687 Employees.(i)
  • NxStage Medical grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.5M383%N/AN/A
#2
$8.3M3314%N/AN/A
#3
$4M1633%N/AN/A
#4
$4.3M17-6%N/AN/A
#5
$5630M69534%$450MN/A
#6
$4M1633%N/AN/A
#7
$7.2M5727%$29.6MN/A
#8
$14.1M560%N/AN/A
#9
$2.1M1731%$44MN/A
#10
$40.9M163-23%N/AN/A
Add Company

NxStage Medical, Inc. was founded in 1998 to develop and market novel technologies for the treatment of kidney failure. The NxStage System One is a breakthrough design that delivers hemodialysis, hemofiltration, and/or ultrafiltration to patients with renal failure or fluid overload. The system is compact and portable; it requires only a standard electrical outlet and no water processing. Its user-friendly interface and drop-in, disposable cartridge are designed for ease-of-use and streamlined training.

keywords:saas

$5.6M

Total Funding

687

Number of Employees

$300M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NxStage Medical News

2022-04-17 - Kidney Dialysis Centers Market SWOT Analysis by Size, Status ...

& Nxstage Medical, Inc.. Staying ahead in business is often about being the first; check the pulse of Kidney Dialysis Centers Market know what...

2022-04-17 - Dialysis Market Size And Forecast | Nikkiso Co. Ltd., NxStage ...

Ltd., NxStage Medical Medicators, Fresenius Medical Care AG & Co. KGaA, B. Braun Avitum AG, Diaverum Deutschland GmbH, NiproCorporation,...

2022-04-17 - Global Dialysis Devices Market to Progress at a Substantial CAGR of 4.84% Reaching USD 94.30 billion by 2026, Asserts DelveInsight

... NxStage Medical, Inc. Infomed SA, Medtronic, Anjue Medical ... Dialysis Devices are medical equipment and consumables that help in...

2015-02-26 - NxStage gains on Q4, 2014 beats, opens Boston dialysis centers

NxStage Medical (NSDQ:NXTM) shares are up today after the home hemodialysis company reported better-than-forecast results for the 4th quarter and 2014 and said it opened 2 new dialysis centers in the Boston area. Lawrence, Mass.-based NxStage pared its losses by 3.9% to -$5.0 million, or -8¢ pe ...

2014-09-18 - Press Release: NxStage announces FDA clearance of Single Needle Technology

LAWRENCE, Mass. — NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite, has received FDA clearance. The OneSite employs a unique dual lumen needle design offered in both a sharp version with MasterGu ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$195M774N/AN/A
#2
$284.8M11307%N/A
#3
$371.2M1473N/AN/A
#4
$564.7M14942%N/A
#5
$586.3M1551-1%N/A